0.9588
6.00%
-0.0612
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Vaxart Inc Aktie (VXRT) Neueste Nachrichten
Vaxart GAAP EPS of -$0.14 in-line, revenue of $2.18M beats by $1.38M - MSN
MSN
Is the Options Market Predicting a Spike in Vaxart (VXRT) Stock? - Yahoo New Zealand News
Yahoo New Zealand News
Vaxart (NASDAQ:VXRT) Share Price Crosses Above Two Hundred Day Moving Average of $0.89 - MarketBeat
MarketBeat
Vaxart (NASDAQ:VXRT) Shares Pass Above 200-Day Moving Average of $0.89 - Defense World
Defense World
Vaxart, Inc. (NASDAQ:VXRT) Q1 2024 Earnings Call Transcript - Insider Monkey
Insider Monkey
Earnings call: Vaxart posts progress in vaccine trials, Q1 financials - Investing.com
Investing.com
Vaxart earnings missed by $0.02, revenue topped estimates - Investing.com ZA - Investing.com South Africa
Investing.com South Africa
Vaxart up 10% on quarterly revenue beat, eyes COVID oral vaccine trial start in Q2 - Seeking Alpha
Seeking Alpha
Vaxart Stock Climbs After Blockbuster Q1 Revenue - Vaxart (NASDAQ:VXRT) - Benzinga
Benzinga
Vaxart Provides Business Update and Reports First Quarter 2024 Financial Results - GlobeNewswire
GlobeNewswire
Vaxart Provides Business Update and Reports First Quarter 2024 Financial Results - Yahoo Finance
Yahoo Finance
All You Need to Know About VAXART, INC. (VXRT) Rating Upgrade to Buy - Yahoo Movies Canada
Yahoo Movies Canada
Vaxart (VXRT) Scheduled to Post Earnings on Monday - MarketBeat
MarketBeat
Vaxart (VXRT) to Release Earnings on Monday - MarketBeat
MarketBeat
Vaxart to Host First Quarter 2024 Business Update and Financial Results Conference Call on May 13 - Investing.com South Africa
Investing.com South Africa
Vaxart to Host First Quarter 2024 Business Update and Financial Results Conference Call on May 13 - Investing.com India
Investing.com India
VAXART, INC. (VXRT) Reports Q4 Loss, Lags Revenue Estimates - Yahoo Movies Canada
Yahoo Movies Canada
Vaxart (NASDAQ:VXRT) Stock Price Crosses Below 200-Day Moving Average of $0.88 - MarketBeat
MarketBeat
Vaxart (NASDAQ:VXRT) Share Price Passes Below 200 Day Moving Average of $0.88 - Defense World
Defense World
Do Options Traders Know Something About Vaxart (VXRT) Stock We Don't? - Yahoo News Australia
Yahoo News Australia
Vaxart announces results for bivalent norovirus vaccine candidate - TipRanks.com - TipRanks
TipRanks
Vaxart Announces Positive Results for Its Bivalent Norovirus Vaccine Candidate in Lactating Mothers
GlobeNewswire Inc.
Vaxart Announces Positive Results for Its Bivalent Norovirus Vaccine Candidate in Lactating Mothers - GlobeNewswire
GlobeNewswire
Vaxart (NASDAQ:VXRT) Shares Cross Below 200-Day Moving Average of $0.88 - Defense World
Defense World
Vaxart, Inc. – Meet the CEO - Vaxart, Inc.
Vaxart, Inc.
Hedge Fund Beats Vaxart Investor's 'Short-Swing' Profits Suit - Law360
Law360
Vaxart to Present at World Vaccine Congress Washington 2024 on April 3
GlobeNewswire Inc.
Vaxart to Present at World Vaccine Congress Washington 2024 on April 3 - GlobeNewswire
GlobeNewswire
Vaxart reports inducement grants under Nasdaq listing rule - TipRanks.com - TipRanks
TipRanks
Vaxart, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire Inc.
Vaxart reports inducement grants under Nasdaq listing rule - TipRanks.com - TipRanks
TipRanks
Vaxart, Inc. (NASDAQ:VXRT) Q4 2023 Earnings Call Transcript - Yahoo Finance
Yahoo Finance
Vaxart Provides Business Update and Reports Full Year 2023 Financial Results
GlobeNewswire Inc.
Vaxart Inc (VXRT) Reports Full Year 2023 Financial Results - Yahoo Finance
Yahoo Finance
Beat the Market Like Zacks: Walmart, Novo Nordisk, Procter & Gamble in Focus
Zacks Investment Research
Vaxart to Host Full Year 2023 Business Update and Financial Results Conference Call on March 14
GlobeNewswire Inc.
Vaxart to Host Full Year 2023 Business Update and Financial Results Conference Call on March 14 - Yahoo Finance
Yahoo Finance
Vaxart appoints Steven Lo as new President and CEO - Investing.com
Investing.com
Vaxart Inc Launches New Equity Plan to Attract Talent - TipRanks.com - TipRanks
TipRanks
VAXART, INC. (VXRT) is a Great Momentum Stock: Should You Buy?
Zacks Investment Research
VAXART, INC. (VXRT) is a Great Momentum Stock: Should You Buy? - Yahoo Finance
Yahoo Finance
5 Top-Ranked Stocks That Have More Than Doubled Year to Date
Zacks Investment Research
5 Top-Ranked Stocks That Have More Than Doubled Year to Date - Yahoo Finance
Yahoo Finance
Investors in Vaxart (NASDAQ:VXRT) from three years ago are still down 81%, even after 19% gain this past week - Simply Wall St
Simply Wall St
VAXART, INC. (VXRT) Now Trades Above Golden Cross: Time to Buy?
Zacks Investment Research
VAXART, INC. (VXRT) Now Trades Above Golden Cross: Time to Buy? - Yahoo Finance
Yahoo Finance
Vaxart Regains Compliance with Nasdaq Listing Standards - TipRanks.com - TipRanks
TipRanks
Vaxart Announces Publication in Vaccines of Non-Human Primate Preclinical Data Demonstrating Its Next-Generation Vaccine Candidates Elicit Mucosal and Systemic Immunogenicity and Reduce Viral Shedding after SARS-CoV-2 Challenge
GlobeNewswire Inc.
Thinking about buying stock in Cano Health, Vaxart, Macy's, Albemarle Corp, or BioXcel Therapeutics? - PR Newswire
PR Newswire
Biggest stock movers today: Etsy, Shell, Vaxart, Rocket Lab, and more (NASDAQ:PTON) - Seeking Alpha
Seeking Alpha
Kapitalisierung:
|
Volumen (24h):